Poseida Therapeutics Announces Carl June, M D , to Chair Immuno-Oncology Scientific Advisory Board apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Date Time
Dana-Farber research leads to better understanding of immune system in kidney cancer
Two research papers highlight single-cell dissection of kidney tumors to identify new immunotherapy treatments and targets
In the last two decades, immunotherapy has emerged as a leading treatment for advanced renal carcinoma cancer (more commonly known as kidney cancer). This therapy is now part of the standard of care, but it doesn’t work for all patients, and almost all patients, no matter how they respond initially, become more resistant to treatment over time. The immune system plays a critical role in kidney cancer disease progression and in response to therapies, and so a fundamental challenge in the field is to understand the underlying “immune circuitry” of this disease.
Dana-Farber research leads to better understanding of the immune system in kidney cancer eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
PICI awards $3 million to support early career cancer researchers
From improving immunotherapy response in childhood cancer patients, to better understanding how cancer s spread to the liver affects the body s immune system, to helping T cells stay energized to fight cancer, The Parker Institute for Cancer Immunotherapy (PICI) s 2021 class of early career researchers award recipients are pursuing ideas that have the potential to change the face of oncology. The awardees, officially announced today, are now empowered to advance their boldest ideas thanks to almost $3 million in support, as well as guidance from and collaboration with PICI s world-class network of immunotherapy experts.
INOVIO to Present at Upcoming Investor Conferences in March
News provided by
Share this article
Share this article
PLYMOUTH MEETING, Pa., March 4, 2021 /PRNewswire/ INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced that Dr. J. Joseph Kim, President and CEO, along with other members of INOVIO management, will present at the following investor conferences in March:
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Virtual 1x1 meetings only
Date: Thursday, March 18, 2021
Time: 10:40 a.m. ET
Presentation Format: Corporate Presentation